Leber congenital amaurosis
| Leber congenital amaurosis | |
|---|---|
| Synonyms | LCA |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Severe vision loss or blindness at birth |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, Electroretinography |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Gene therapy, Low vision aids |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | 2-3 per 100,000 newborns |
| Deaths | N/A |
Leber congenital amaurosis (LCA) is a rare genetic eye disorder that appears at birth or in the first few months of life. It affects around 1 in 80,000 of the population. The condition was first described by Theodor Leber in the 19th century.
Symptoms[edit]
The most common symptoms of LCA include severe visual impairment from birth, involuntary movements of the eyes (nystagmus), and deep-set eyes. The condition can also cause keratoconus, cataract, and a sensitivity to light (photophobia).
Causes[edit]
LCA is caused by mutations in at least 14 different genes, all of which are necessary for normal vision. These genes are involved in the development of photoreceptor cells in the retina. Mutations in these genes can affect the structure and function of these cells, leading to the symptoms of LCA.
Diagnosis[edit]
Diagnosis of LCA is based on clinical examination and genetic testing. The clinical examination may include an electroretinogram (ERG), which measures the electrical responses of various cell types in the retina. Genetic testing can confirm the diagnosis and identify the specific gene mutation causing the condition.
Treatment[edit]
There is currently no cure for LCA, but treatments are available to help manage the symptoms. These may include visual aids, mobility training, and occupational therapy. In some cases, gene therapy may be an option.
Research[edit]
Research into LCA is ongoing, with scientists exploring gene therapy, stem cell therapy, and other treatments. Clinical trials are also being conducted to evaluate potential new treatments.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


